GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
F., Battaglia, G., Palma, A., & Paoli, A
The current standard treatment CPAP has several disadvantages, including low compliance, reliance on hospital-based clinic devices, and potential weight gain, which is not conducive to long-term disease control [24]
Start by washing your hands with soap and water, then clean the injection site with an alcohol swab
Caution is needed with a history of pancreatitis, gallbladder disease, severe gastrointestinal conditions such as gastroparesis, diabetic retinopathy, or certain other medications, including insulin and sulfonylureas